Cargando…
Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is characterized by increased left ventricular wall thickness, cardiomyocyte hypertrophy, and fibrosis. Adverse cardiac risk characterization has been performed using late gadolinium enhancement (LGE), native T1, and extracellular volume (ECV). Relaxatio...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543937/ https://www.ncbi.nlm.nih.gov/pubmed/34689798 http://dx.doi.org/10.1186/s12968-021-00813-5 |
_version_ | 1784589714285658112 |
---|---|
author | Thompson, Elizabeth W. Kamesh Iyer, Srikant Solomon, Michael P. Li, Zhaohuan Zhang, Qiang Piechnik, Stefan Werys, Konrad Swago, Sophia Moon, Brianna F. Rodgers, Zachary B. Hall, Anya Kumar, Rishabh Reza, Nosheen Kim, Jessica Jamil, Alisha Desjardins, Benoit Litt, Harold Owens, Anjali Witschey, Walter R. T. Han, Yuchi |
author_facet | Thompson, Elizabeth W. Kamesh Iyer, Srikant Solomon, Michael P. Li, Zhaohuan Zhang, Qiang Piechnik, Stefan Werys, Konrad Swago, Sophia Moon, Brianna F. Rodgers, Zachary B. Hall, Anya Kumar, Rishabh Reza, Nosheen Kim, Jessica Jamil, Alisha Desjardins, Benoit Litt, Harold Owens, Anjali Witschey, Walter R. T. Han, Yuchi |
author_sort | Thompson, Elizabeth W. |
collection | PubMed |
description | BACKGROUND: Hypertrophic cardiomyopathy (HCM) is characterized by increased left ventricular wall thickness, cardiomyocyte hypertrophy, and fibrosis. Adverse cardiac risk characterization has been performed using late gadolinium enhancement (LGE), native T1, and extracellular volume (ECV). Relaxation time constants are affected by background field inhomogeneity. T1ρ utilizes a spin-lock pulse to decrease the effect of unwanted relaxation. The objective of this study was to study T1ρ as compared to T1, ECV, and LGE in HCM patients. METHODS: HCM patients were recruited as part of the Novel Markers of Prognosis in Hypertrophic Cardiomyopathy study, and healthy controls were matched for comparison. In addition to cardiac functional imaging, subjects underwent T1 and T1ρ cardiovascular magnetic resonance imaging at short-axis positions at 1.5T. Subjects received gadolinium and underwent LGE imaging 15–20 min after injection covering the entire heart. Corresponding basal and mid short axis LGE slices were selected for comparison with T1 and T1ρ. Full-width half-maximum thresholding was used to determine the percent enhancement area in each LGE-positive slice by LGE, T1, and T1ρ. Two clinicians independently reviewed LGE images for presence or absence of enhancement. If in agreement, the image was labeled positive (LGE + +) or negative (LGE −−); otherwise, the image was labeled equivocal (LGE + −). RESULTS: In 40 HCM patients and 10 controls, T1 percent enhancement area (Spearman’s rho = 0.61, p < 1e-5) and T1ρ percent enhancement area (Spearman’s rho = 0.48, p < 0.001e-3) correlated with LGE percent enhancement area. T1 and T1ρ percent enhancement areas were also correlated (Spearman’s rho = 0.28, p = 0.047). For both T1 and T1ρ, HCM patients demonstrated significantly longer relaxation times compared to controls in each LGE category (p < 0.001 for all). HCM patients also showed significantly higher ECV compared to controls in each LGE category (p < 0.01 for all), and LGE −− slices had lower ECV than LGE + + (p = 0.01). CONCLUSIONS: Hyperenhancement areas as measured by T1ρ and LGE are moderately correlated. T1, T1ρ, and ECV were elevated in HCM patients compared to controls, irrespective of the presence of LGE. These findings warrant additional studies to investigate the prognostic utility of T1ρ imaging in the evaluation of HCM patients. |
format | Online Article Text |
id | pubmed-8543937 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85439372021-10-25 Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy Thompson, Elizabeth W. Kamesh Iyer, Srikant Solomon, Michael P. Li, Zhaohuan Zhang, Qiang Piechnik, Stefan Werys, Konrad Swago, Sophia Moon, Brianna F. Rodgers, Zachary B. Hall, Anya Kumar, Rishabh Reza, Nosheen Kim, Jessica Jamil, Alisha Desjardins, Benoit Litt, Harold Owens, Anjali Witschey, Walter R. T. Han, Yuchi J Cardiovasc Magn Reson Research BACKGROUND: Hypertrophic cardiomyopathy (HCM) is characterized by increased left ventricular wall thickness, cardiomyocyte hypertrophy, and fibrosis. Adverse cardiac risk characterization has been performed using late gadolinium enhancement (LGE), native T1, and extracellular volume (ECV). Relaxation time constants are affected by background field inhomogeneity. T1ρ utilizes a spin-lock pulse to decrease the effect of unwanted relaxation. The objective of this study was to study T1ρ as compared to T1, ECV, and LGE in HCM patients. METHODS: HCM patients were recruited as part of the Novel Markers of Prognosis in Hypertrophic Cardiomyopathy study, and healthy controls were matched for comparison. In addition to cardiac functional imaging, subjects underwent T1 and T1ρ cardiovascular magnetic resonance imaging at short-axis positions at 1.5T. Subjects received gadolinium and underwent LGE imaging 15–20 min after injection covering the entire heart. Corresponding basal and mid short axis LGE slices were selected for comparison with T1 and T1ρ. Full-width half-maximum thresholding was used to determine the percent enhancement area in each LGE-positive slice by LGE, T1, and T1ρ. Two clinicians independently reviewed LGE images for presence or absence of enhancement. If in agreement, the image was labeled positive (LGE + +) or negative (LGE −−); otherwise, the image was labeled equivocal (LGE + −). RESULTS: In 40 HCM patients and 10 controls, T1 percent enhancement area (Spearman’s rho = 0.61, p < 1e-5) and T1ρ percent enhancement area (Spearman’s rho = 0.48, p < 0.001e-3) correlated with LGE percent enhancement area. T1 and T1ρ percent enhancement areas were also correlated (Spearman’s rho = 0.28, p = 0.047). For both T1 and T1ρ, HCM patients demonstrated significantly longer relaxation times compared to controls in each LGE category (p < 0.001 for all). HCM patients also showed significantly higher ECV compared to controls in each LGE category (p < 0.01 for all), and LGE −− slices had lower ECV than LGE + + (p = 0.01). CONCLUSIONS: Hyperenhancement areas as measured by T1ρ and LGE are moderately correlated. T1, T1ρ, and ECV were elevated in HCM patients compared to controls, irrespective of the presence of LGE. These findings warrant additional studies to investigate the prognostic utility of T1ρ imaging in the evaluation of HCM patients. BioMed Central 2021-10-25 /pmc/articles/PMC8543937/ /pubmed/34689798 http://dx.doi.org/10.1186/s12968-021-00813-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Thompson, Elizabeth W. Kamesh Iyer, Srikant Solomon, Michael P. Li, Zhaohuan Zhang, Qiang Piechnik, Stefan Werys, Konrad Swago, Sophia Moon, Brianna F. Rodgers, Zachary B. Hall, Anya Kumar, Rishabh Reza, Nosheen Kim, Jessica Jamil, Alisha Desjardins, Benoit Litt, Harold Owens, Anjali Witschey, Walter R. T. Han, Yuchi Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy |
title | Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy |
title_full | Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy |
title_fullStr | Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy |
title_full_unstemmed | Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy |
title_short | Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy |
title_sort | endogenous t1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543937/ https://www.ncbi.nlm.nih.gov/pubmed/34689798 http://dx.doi.org/10.1186/s12968-021-00813-5 |
work_keys_str_mv | AT thompsonelizabethw endogenoust1rcardiovascularmagneticresonanceinhypertrophiccardiomyopathy AT kameshiyersrikant endogenoust1rcardiovascularmagneticresonanceinhypertrophiccardiomyopathy AT solomonmichaelp endogenoust1rcardiovascularmagneticresonanceinhypertrophiccardiomyopathy AT lizhaohuan endogenoust1rcardiovascularmagneticresonanceinhypertrophiccardiomyopathy AT zhangqiang endogenoust1rcardiovascularmagneticresonanceinhypertrophiccardiomyopathy AT piechnikstefan endogenoust1rcardiovascularmagneticresonanceinhypertrophiccardiomyopathy AT weryskonrad endogenoust1rcardiovascularmagneticresonanceinhypertrophiccardiomyopathy AT swagosophia endogenoust1rcardiovascularmagneticresonanceinhypertrophiccardiomyopathy AT moonbriannaf endogenoust1rcardiovascularmagneticresonanceinhypertrophiccardiomyopathy AT rodgerszacharyb endogenoust1rcardiovascularmagneticresonanceinhypertrophiccardiomyopathy AT hallanya endogenoust1rcardiovascularmagneticresonanceinhypertrophiccardiomyopathy AT kumarrishabh endogenoust1rcardiovascularmagneticresonanceinhypertrophiccardiomyopathy AT rezanosheen endogenoust1rcardiovascularmagneticresonanceinhypertrophiccardiomyopathy AT kimjessica endogenoust1rcardiovascularmagneticresonanceinhypertrophiccardiomyopathy AT jamilalisha endogenoust1rcardiovascularmagneticresonanceinhypertrophiccardiomyopathy AT desjardinsbenoit endogenoust1rcardiovascularmagneticresonanceinhypertrophiccardiomyopathy AT littharold endogenoust1rcardiovascularmagneticresonanceinhypertrophiccardiomyopathy AT owensanjali endogenoust1rcardiovascularmagneticresonanceinhypertrophiccardiomyopathy AT witscheywalterrt endogenoust1rcardiovascularmagneticresonanceinhypertrophiccardiomyopathy AT hanyuchi endogenoust1rcardiovascularmagneticresonanceinhypertrophiccardiomyopathy |